CMP Risk Assessment Publications Plan for April to June 2022
Quarterly Consumer Product and Cosmetic Reports Received Summary for Q3 2021-2022
Performance Standards for NHP Applications – March 23, 2022
Update on the Revised In Commerce List (R-ICL)
Administration of the New Substances program – Processing of Submissions document
Recycled content for Plastic Manufactured Items
An Update on the Proposed Amendments to the Food and Drugs Act for the Assessment and Management of Environmental Risk from Drugs
Extension: Survey on Health Canada’s Pilot NHP GMP Inspection Program
Guidance Document: Regulatory Requirements for Drug Identification Numbers (DINs) – Summary
Cosmetic Notification Form Update
